Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Winding Down White Oak Construction; Outside Rents Going Up

Executive Summary

President Obama’s budget requests less headquarters consolidation funding in FY 2015 as CBER announces it will move staff to the campus between May and July.

You may also be interested in...



Smallpox Discovery Prompts FDA Action Plan; Move To White Oak Unchanged

FDA scientist’s discovery of decades-old vials of smallpox at lab on NIH campus are a reminder of the unsettled debate on whether governments should keep smallpox stock to aid development of antivirals.

CBER To Pause Receipt Of Lot Release Samples During Move To White Oak

CBER will begin moving to FDA’s main campus about April 25, sooner than initially expected; OGD will relocate about the same time.

FDA Budget: Compounding Increase Paid With Construction Funding, Efficiencies

Some planned buildings on the White Oak campus for FY 2015 would not be funded and savings from program efficiencies would create the $25 million in new funding for compounding oversight, Hamburg tells House committee.

Related Content

Topics

UsernamePublicRestriction

Register

OM006922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel